Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • English
    • Deutsch
    • Français
    • Italiano
    • Português
    • Español
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Dermatology
      • Atopic dermatitis and psoriasis news
      • Dermatology News
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
      • Diabetes Podcasts
    • Gastroenterology
      • IBD matters
      • Forum Gastroenterology
      • Ozanimod: ulcerative colitis
      • Reflux Update
    • Immunology
      • Primary immunodeficiency – exchange of experience
    • Vaccinate
      • Herpes zoster
    • Infektiologie
    • Neurology
      • EXPERT ULTRASONIC: Introduction to ultrasound-guided injection
      • MS News
      • MS Therapy in Transition
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Practice Management
      • Aargau Cantonal Bank
      • Claraspital
    • Psychiatry
      • Geriatric Psychiatry
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

astrocytes_wikimedia
  • Research: Expression of Lcn2 in Reactive Astrocytes

RNA Nanotherapeutics Inhibit the Propagation of Neurotoxic Astroglial Responses Following Brain Injuries

    • Neurology
    • News
    • RX
    • Studies
  • 2 minute read

Research from the Department of Clinical Neurosciences and Stem Cell Institute at Cambridge University demonstrates that RNA nanotherapeutics curtail the production of an inflammation-spreading signal released by cells of the central nervous system (CNS) in response to injury or disease.

Astrocytes are a ubiquitous and functionally-diverse class of cells found in the CNS where they play essential roles in regulating physiological processes such as synaptic transmission and blood-brain barrier integrity. Insults to the CNS, including conditions as diverse as traumatic injuries of the brain and spinal cord, multiple sclerosis, brain stroke and Alzheimer’s disease, are known to invoke a reactive state in astrocytes during which these cells undergo a variety of morphological and functional changes. Astroglial changes can be beneficial or detrimental, depending on the type, timing and context of the insult. Reactive astroglial cells typically increase the expression and release of the inflammation- and reactivity-propagating protein Lipocalin 2 (Lcn2). Lcn2 secreted by reactive astrocytes is known to promote reactivity in otherwise resting astrocytes, polarise immune cells towards a pro-inflammatory state, and have toxic effects on neurons.

Using the bio-inspired three-way junction (3WJ) RNA nanotechnology originally developed in the lab of Dr. Peixuan Guo at Ohio State University (USA), Smith et al. demonstrated that RNA interference can efficaciously and safely down-regulate the expression of Lcn2 in reactive astrocytes in vitro. Moreover, treatment with anti-Lcn2-3WJs significantly impeded the ability of reactive astrocytes to perpetuate a pro-inflammatory state. Resting astrocytes receiving the culture media in which reactive astrocytes had been grown showed a large increase in the expression of Lcn2 and nitric oxide synthase 2 (Nos2), an enzyme that produces free radicals and is associated with inflammation. Treating the original reactive astrocytes with anti-Lcn2-3WJs negated this effect. Importantly, 3WJ-mediated Lcn2 reduction was also evident in an experimental mouse model of contusion spinal cord injury, with significant reductions in the amount of Lcn2 present in mice treated with the RNA nanotherapeutics.

 

 

This proof-of-concept study has important implications for the treatment of brain disorders in which inflammation is often a contributing factor in the pathology. The approach is especially well-suited to combinatorial treatments in which the inhospitable tissue microenvironment fostered by the local increase in Lcn2 might prove inhibitory to other putative regenerative interventions, such as small molecules or stem cell therapeutics. Moreover, the modular, multiarmed nature of the 3WJ nanostructure lends itself to further functionalisation, with the potential for engineering targeting and/or diagnostic capabilities into the platform for the development of cell-specific therapeutics.

This research was funded by the International Foundation for Research in Paraplegia, the Bascule Charitable Trust, the UK Regenerative Medicine Platform, and Wings for Life.

Source: Full article in: Molecular Therapy – Nucleic Acids, Elsevier

Publication details (article available as advance online publication): Smith JA, Braga A, Pluchino S, et. al.: RNA nanotherapeutics for the amelioration of astroglial reactivity. www.sciencedirect.com/science/article/pii/S2162253117302925

 

IRP – International Foundation
for Research in Paraplegia
Seestrasse 19
8002 Zürich
www.irp.ch

Partner
  • irp_logo
Publikation
  • HAUSARZT PRAXIS
Related Topics
  • astrocytes
Previous Article
  • A risky interaction

Cannabis and incipient psychosis

  • Education
  • Psychiatry and psychotherapy
  • RX
View Post
Next Article
  • 21st Annual Meeting of the Swiss Stroke Society 2018, Lausanne

Cerebral stroke in elderly, polymorbid patients.

  • Congress Reports
  • Geriatrics
  • Neurology
  • RX
  • Studies
View Post
You May Also Like
View Post
  • 5 min
  • Asthma in adults

When do pneumology specialists come into play?

    • RX
View Post
  • 10 min
  • Cutaneous lupus erythematosus

From diagnostic workup to successful treatment

    • Congress Reports
    • Dermatology and venereology
    • RX
    • Studies
View Post
  • 4 min
  • Guideline update

Dietary recommendations for Crohn’s disease and colitis

    • Education
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 4 min
  • Circadian rhythm during Ramadan

Disturbed sleep patterns lead to metabolic stress

    • Education
    • Endocrinology and Diabetology
    • General Internal Medicine
    • Nutrition
    • RX
    • Studies
View Post
  • 6 min
  • Case Report

Breast cancer metastases in the bladder

    • Cases
    • Education
    • Gynecology
    • Oncology
    • RX
    • Urology
View Post
  • 11 min
  • Findings from the ALS Symposium 2024 in Montreal

Current and future approaches in the treatment of amyotrophic lateral sclerosis (ALS)

    • Congress Reports
    • Interviews
    • Neurology
    • RX
    • Studies
View Post
  • 8 min
  • Efficacy, mechanism of action and clinical effects

Garlic and high blood pressure

    • Cardiology
    • Education
    • General Internal Medicine
    • Pharmaceutical medicine
    • Phytotherapy
    • RX
    • Studies
View Post
  • 7 min
  • Moderate to severe chronic hand eczema

Delgocitinib cream – first topical pan-JAK inhibitor approved in Switzerland

    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Infectiology
    • Market & Medicine
    • Pharmacology and toxicology
    • RX
Top Partner Content
  • Forum Gastroenterology

    Zum Thema
  • Herpes zoster

    Zum Thema
  • Dermatology News

    Zum Thema
Top CME content
  • 1
    Patience, knowledge and persistence in therapy
  • 2
    Sarcopenia and malnutrition in the context of pneumological rehabilitation
  • 3
    Medical and psychosocial perspectives
  • 4
    New nomenclature for non-alcoholic fatty liver disease
  • 5
    Examinations and considerations before therapy

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.